Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 5,752 | 4,324 | 3,318 | 4,219 | 6,476 |
| Cost of Goods | 3,030 | 2,242 | 1,791 | 2,492 | 3,966 |
| Gross Profit | 2,722 | 2,082 | 1,527 | 1,727 | 2,510 |
| Operating Expenses | 7,269 | 7,807 | 7,386 | 8,818 | 8,892 |
| Operating Income | -4,517 | -5,483 | -5,068 | -6,599 | -5,416 |
| Interest Expense | 357 | 1,553 | 2,163 | 1,902 | 1,954 |
| Other Income | 4 | 1,779 | -150 | -29 | -15 |
| Pre-tax Income | -4,870 | -5,257 | -7,381 | -8,530 | -7,385 |
| Net Income Continuous | -4,870 | -5,257 | -7,381 | -8,530 | -7,385 |
| Net Income | $-4,870 | $-5,257 | $-7,381 | $-8,530 | $-7,385 |
| EPS Basic Total Ops | -0.04 | -0.07 | -0.23 | -0.27 | -0.25 |
| EPS Basic Continuous Ops | -0.04 | -0.07 | -0.23 | -0.27 | -0.25 |
| EPS Diluted Total Ops | -0.04 | -0.07 | -0.23 | -0.27 | -0.25 |
| EPS Diluted Continuous Ops | -0.04 | -0.07 | -0.23 | -0.27 | -0.25 |
| EBITDA(a) | $-4,012 | $-5,005 | $-4,564 | $-6,093 | $-4,903 |